This project will provide a cancer-selective, phosphatidylserine (PS)-targeted radiolabeled nanovesicle system for targeted radionuclide therapy (TRT) of brain tumors.
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201700037C
- Awardee
-
Molecular Targeting Technologies, Inc. UEI Y2FNW7N1V267
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $349,989
Award facts
- Opportunity
-
- PHS20171 Solicitation number
- Contract value 87% obligated
-
- $349,989.00 Current, with exercised options
- $399,989.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- West Chester, PA, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $50,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $299,989 |
About this award
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, part of the National Institutes of Health at the Department of Health and Human Services. The $399,989 Firm Fixed Price contract was awarded to Molecular Targeting Technologies, Inc. (MTTI) on September 18, 2017 to develop a cancer-selective, phosphatidylserine (PS)-targeted radiolabeled nanovesicle system for targeted radionuclide therapy of brain tumors. The contract has a completion date of December 17, 2018 and is designated as a Total Small Business set-aside.
Quick answers
Who was awarded contract HHSN261201700037C?
HHSN261201700037C was awarded to Molecular Targeting Technologies, Inc. by National Cancer Institute (National Institutes of Health) on September 18, 2017.
How much is contract HHSN261201700037C worth?
The government has obligated $349,989 on HHSN261201700037C. Its potential value, with all options, is $399,989.
Was contract HHSN261201700037C competed?
The extent of competition for HHSN261201700037C was full and open competition after exclusion of sources. The government received 12 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award